The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2016. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Among the most popular portfolio startups of the fund, we may highlight Promethera Biosciences. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Pharmaceutical.
The standard case for the fund is to invest in rounds with 7 partakers. Despite the SMS Investments, startups are often financed by Shire, Vesalius Biocapital Partners, SFPI-FPIM. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, S.R.I.W., Mitsui Global Investment. In the next rounds fund is usually obtained by Shinsei Corporate Investment Limited, Shibuya Kogyo, Sansei Capital Investment.
The overall number of key employees were 3.
Related Funds
| Fund Name | Location |
| Brighton Park Capital | Connecticut, Greenwich, United States |
| Cavatina Capital | Puerto Rico, San Juan, United States |
| Great Spirit Ventures | California, Mill Valley, United States |
| Kerala State Electricity Board | - |
| Maniv Energy Capital | Englewood Cliffs, New Jersey, United States |
| New Vision Ventures | Beijing, Beijing, China |
| Nichirei | Japan, Tokyo |
| Vitulum Ventures | Amsterdam, Noord-Holland, The Netherlands |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Promethera Biosciences | $11M | 27 Oct 2016 | Walloon Brabant |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Promethera Biosciences | $11M | 27 Oct 2016 | Walloon Brabant |
